Bell Asset Management’s Amedisys AMED Stock Holding History
Bought
Maintained
Sold
Other funds holding AMED
RP
BG
Bell Asset Management's AMED Position: Q3 2022 in Review
Bell Asset Management sold out of Amedisys (AMED) in Q3 2022, closing a stake of 48,266 shares — an estimated $5.07M sold.
Bell Asset Management first reported a position in AMED in Q3 2021 and held it in 4 quarters. The position peaked at $8.13M in Q1 2022. 286 funds tracked by Wall St. Rank hold AMED as of Q3 2022.
- Bell Asset Management reported no remaining Amedisys position as of Q3 2022 after selling out during the quarter.
- Bell Asset Management sold 48,266 Amedisys shares in Q3 2022, an estimated $5.07M.
- Bell Asset Management first reported a position in Amedisys in Q3 2021 and held it in 4 quarters.
- Bell Asset Management's Amedisys position peaked at $8.13M in Q1 2022.
- 286 funds tracked by Wall St. Rank held Amedisys as of Q3 2022.
Based on Bell Asset Management's 13F filing for Q3 2022, filed 10 Nov 2022.